Kidney Disease Clinical Trials

Showing 2221-2240 of 3,902 trials

Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients

NCT01447485

This study will assess the pharmacokinetics and safety following single dose of valsartan in Japanese pediatric patients with hypertension, chronic kidney disease, or nephrotic syndrome.

HypertensionChronic Kidney DiseaseNephrotic Syndrome

Novartis Pharmaceuticals12 participantsStarted Aug 2011

Aichi, Japan • Tokyo, Japan

COMPLETEDPhase 3

Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients

NCT01069692

This study will compare placebo to 4 different doses of SBR759 to assess the phosphate lowering efficacy in dialysis patients.

HyperphosphatemiaChronic Kidney Disease

Novartis115 participantsStarted Feb 2010

Jette, Belgium • Liège, Belgium • Roeselare, Belgium +6 more locations

COMPLETEDPhase 1/2

A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis

NCT00750295

The primary objective of this study is to assess the safety, tolerability and activity of escalating multiple doses of SBR759 in patients with chronic kidney disease on hemodialysis.

Chronic Kidney Disease

Novartis Pharmaceuticals60 participantsStarted Feb 2007

Denver, Colorado, United States

Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients

Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients

A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis

Related Searches

A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body

Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions

Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis

Changes in Renal Function and Body Composition in Pulmonary Hypertension

Role of AST120 for Sarcopenia Prevention in Pre-dialysis Chronic Kidney Disease

Observation on the Effect of Auricular Acupoint Pressing on Insomnia and Adverse Events in MHD

Sarcopenia and Physical Performance in Hemodialysis Patients

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria

C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19

A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients

Light Therapy on Sleep Quality in Dialysis Patients

Stent-related Symptoms Comparison: Polaris Loop vs Vortek Double-J Stents

Determinants of Cardiovascular Disease, Kidney Disease and Diabetes

Remote Physician Care for Home Hospital Patients

Clinical Evaluation of PROMIS in CKD